Home           |           About Us           |           Register Free           |           Events and Conferences           |           Contact Us

The Dubai Biotechnology and Research Park (DuBiotech is all set to become a center of excellence in biotechnology for the region.

Established as a free zone under the Dubai Technology and Media Free Zone Authority, DuBiotech will create a comprehensive infrastructure and environment to catalyse biotech industry development in the region. Initiated last year, the park is being built in several phases on a 300-hectare area located close to the Dubailand project in an area of over 30 million square feet of built-up area. Its infrastructure offering will comprise of custom-made research and development (R&D) facilities - such as labs, clean rooms and incubators, office space and residential facilities. The first phase of its USD400 million (AED 1.47 billion) biotechnology industry cluster will include its laboratory complex and headquarters. The laboratory complex will be complete by December 2007 followed by the headquarters in September 2008.

DuBiotech and FIZ signs joint agreement in presence of Roland Koch, Prime Minister of German state of Hessen

Groundbreaking agreement between Dubai Biotechnology and Research Park (DuBiotech) and the Frankfurt
Biotechnology Innovation Center (FIZ)

In the presence of Mr. Roland Koch, Prime Minister of the state of Hessen in Germany, Ahmad bin Byat, Director General of Dubai Technology and Media Free Zone and Dr. Christian Garbe, Managing Director of the Frankfurt Biotechnology Innovation Center (FIZ), today signed a Memorandum of Understanding between Dubai Biotechnology and Research Park (DuBiotech) and FIZ to jointly develop in life sciences research, education, professional training, and the development of marketable products in the health sector.

Biotech Free Zone and CERT to boost research with first IBM supercomputer in the Middle East.

HH Sheikh Nahyan bin Mubarak Al Nahyan, UAE Minister of Education and Chairman of the Higher Colleges of Technology and HE Mohammed Al Gergawi, CEO of Dubai Holding, yesterday signed a Memorandum of Understanding (MoU) to work together to provide the Business Partners of Dubai Biotechnology and Research Park (DuBiotech), Dubai’s Free Zone dedicated to the biotechnology, pharmaceutical and life sciences sectors, with the capability to conduct research using IBM’s Blue Gene supercomputer

RESEARCH TRIANGLE PARK, N.C. -- The Dubai Biotechnology and Research Park (DuBiotech) has chosen RTI International to develop the scientific and regulatory standards that will be used by DuBiotech's researchers and business partners to advance biotechnology research and development across the Middle East.

DuBiotech, the first park of its kind in the Middle East, is designed to be the center of excellence in biotechnology that will link government, academia and industry through national and international collaboration to develop new technologies and products to address regional health and environmental issues.

Dubai Biotechnology and Research Park signs Memorandum of Understanding (MoU) with UAE University

The Dubai Biotechnology and Research Park (DuBiotech), the region’s first biotechnology cluster, announced today that it has signed a Memorandum of Understanding (MoU) with the UAE University to create the framework for a partnership to foster research in the UAE.

Through this new partnership DuBiotech and UAE University aim to promote academic-industry links that will advance excellence in biotechnology and pharmaceutical research.

TORONTO, June 16 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (Nasdaq: GNBT), a leader in the area of buccal drug delivery, today announced that it has entered into a Product Licensing & Distribution Agreement pursuant to which MedGen Corp., with the assistance of Generex, will make application to the Lebanese Ministry of Public Health (http://www.public-health.gov.lb) seeking approval for the commercial sale of Oral-lyn(TM), the Company's proprietary oral insulin buccal spray formulation, in the Republic of Lebanon. Generex has granted to MedGen a license to market, promote, distribute, and sell Oral-lyn(TM) in Lebanon following receipt of the MOPH registration. Generex will manufacture and sell Oral-lyn(TM) to MedGen for resale into the Lebanese market under the license.

Guest speakers include a UN official and major industry players

The Dubai Biotechnology and Research Park (DuBiotech), the region’s first business cluster dedicated to biotechnology, today held a conference titled ‘Business in Biotechnology Symposium’, which saw leading international experts speaking about various business aspects of this rapidly growing industry.

The Symposium discussed issues and opportunities surrounding business in this sector. Experts and industry players presented their perspectives on regulations and business strategies in the industry.

Parsons, along with leading scientific design specialists, to develop the infrastructure blueprint for DuBiotech

The Dubai Biotechnology and Research Park (DuBiotech), Dubai’s free zone dedicated to the biotechnology, pharmaceutical and life sciences sectors, has announced that the master plan for its park will be designed by Parsons, a leader in Biotechnology manufacturing engineering, construction management and technical solutions.

Parsons will partner with CUH2A, the world's largest professional services firm dedicated to planning and design of science and technology facilities, to support the development the DuBiotechmaster plan.

DuBiotechhead outlines importance of global benchmarks in life sciences infrastructure for biotech companies

The head of DuBiotech, Dubai’s new free zone dedicated to biotechnology, has outlined the importance of industry-specific regulatory standards and infrastructure required for companies from the biotechnology industry to establish successful operations.

The life sciences sector requires not only specific laboratory designs, but also locations and support infrastructure, including biosafety and waste management support, in order to do business.

Committee, featuring eminent biotech experts, to guide DuBiotechon strategic issues

The Dubai Biotechnology and Research Park (DuBiotech) has announced a steering committee comprised of eminent biotechnology experts that will offer strategic guidance to the new initiative.

The steering committee will advise the DuBiotechmanagement on initiatives to support and foster the growth of the biotechnology industry in the region and enable DuBiotechto respond to new challenges and opportunities in the sector.

New initiative is the world’s first free zone dedicated to biotechnology

DuBiotech to become center of excellence in biotechnology for the region

His Highness General Sheikh Mohammed Bin Rashid Al Maktoum, Crown Prince of Dubai and UAE Defence Minister today announced the Dubai Biotechnology and Research Park (DuBiotech ), the world’s first free zone dedicated to the biotechnology industry.